On this show we talk a lot about the opportunity and the promise of innovation. It is incredibly difficult, however, to study the actual impact of those new technologies. In healthcare, we do have some chance to measure the impact of new medicines. But! What data do we use? What metrics are used? and why are they used? Today’s guest is Dr. Frank Lichtenberg, the Courtney C. Brown Professor of Business at the Graduate School of Business at Columbia University. Dr. Lichtenberg has taught at Columbia, Harvard, and Penn, worked for the Department of Justice, the Congressional Budget Office, and the Census Bureau, and has conducted several large studies on the impact of pharmaceutical innovation across diseases and geographies over the last 25 years. Right now, billions are sheltering in place from a pathogen that we must fight with drugs and vaccines. The purpose of this conversation is to gain a little bit better understanding of an important topic, relayed in the voice of a leading researcher, so that we may, in the future, invent and develop safer, better technologies to fight disease. To do that, we must measure medicine’s impact not only on the patient, but also the patient population, the healthcare system, and the entire economy.

This is the TomorrowScale Podcast. Hosted by Justin Briggs.

Dr. Lichtenberg’s Columbia Page: https://www8.gsb.columbia.edu/cbs-directory/detail/frl1

Dr. Lichtenberg’s Publications via Google Scholar: https://scholar.google.com/citations?hl=en&user=t3NSVwoAAAAJ&view_op=list_works&sortby=pubdate

Listen on Your Favorite Podcast App

The TomorrowScale Podcast was created to showcase scientists and entrepreneurs who are building science-based businesses, and to hear their stories from the benches and in the trenches of research & development. The views expressed by the host and guests are their own, and the content of this show should not be considered legal, tax, or investing advice. Thanks to our guests for sharing their time and knowledge with us. Thank you for listening. Please science responsibly.